Pharmaceutical giant MSD with factory in Tipperary to cut $3bn in costs including jobs


The multi-national that has a plant at Ballydine near Kilsheelan is making the global cutbacks as it prepares for generic competition to its cancer drug Keytruda
Pharmaceutical giant MSD that operates a plant at Ballydine between Kilsheelan and Carrick-on-Suir has announced $3bn (€2.59bn) in global cost cuts as it prepares for generic competition to its cancer drug Keytruda.
Keytruda is the the world's best-selling medicine, which is predominantly made in Ireland.
The company will cut administrative, sales and research jobs, with increased focus on the US market.
It's not known yet where the jobs will be lost and if any of its Irish workforce will be affected.
MSD employs more than 3,000 people at eight locations in Ireland, including MSD Ballydine, which was the company's first Irish factory. The other factories are MSD Brinny, Co. Cork, MSD Biotech, MSD Blackrock and MSD Red Oak North in Dublin, MSD Carlow, MSD Dunboyne in Co. Meath and MSD Dundalk.